Jude Cloud [32] and observed that RBM5 is broadly expressed in different molecular subtypes of AML and significantly higher in CEBPA mutated, NPM1-mutated and KMT2A-r subtypes (Additional file 1: Fig. S1d). Here, KMT2A is linked to acute myeloid leukemia.